PubMed:9726970
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-121 | Sentence | denotes | p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. |
| T2 | 122-424 | Sentence | denotes | We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by alpha-interferon (alpha-IFN). alpha-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. |
| T3 | 425-681 | Sentence | denotes | However, the change in p130 phosphorylation in response to alpha-IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G1, whereas pRb is dephosphorylated only in G1. |
| T4 | 682-930 | Sentence | denotes | In contrast, p107 is dephosphorylated and is then depleted from cells as they exit the cell cycle. p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F-4, whereas pRb binds both E2F-4 and E2F-1. |
| T5 | 931-1095 | Sentence | denotes | The phosphorylated forms of E2F-4 that bind to the E2F DNA site are different from hyperphosphorylated E2F-4, which predominates in primary hemopoietic cells in G0. |
| T6 | 1096-1347 | Sentence | denotes | We conclude that although cell cycle arrest induced by alpha-IFN may be mediated in part by formation of a complex containing p130 and E2F-4, alpha-IFN does not induce hyperphosphorylation of E2F-4, which characterizes primary hemopoietic cells in G0. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein | denotes | p130 |
| T2 | 6-10 | protein | denotes | p107 |
| T3 | 16-19 | protein | denotes | pRb |
| T4 | 52-71 | cell_type | denotes | proliferating cells |
| T5 | 104-120 | protein | denotes | alpha-interferon |
| T6 | 172-193 | protein | denotes | retinoblastoma family |
| T7 | 195-198 | protein | denotes | pRb |
| T8 | 200-204 | protein | denotes | p107 |
| T9 | 210-214 | protein | denotes | p130 |
| T10 | 263-276 | cell_line | denotes | Daudi B-cells |
| T11 | 313-329 | protein | denotes | alpha-interferon |
| T12 | 331-340 | protein | denotes | alpha-IFN |
| T13 | 343-352 | protein | denotes | alpha-IFN |
| T14 | 381-384 | protein | denotes | pRb |
| T15 | 397-423 | protein | denotes | p130 phosphorylated Form 3 |
| T16 | 448-452 | protein | denotes | p130 |
| T17 | 484-493 | protein | denotes | alpha-IFN |
| T18 | 529-532 | protein | denotes | pRb |
| T19 | 561-572 | protein | denotes | p130 Form 3 |
| T20 | 646-649 | protein | denotes | pRb |
| T21 | 695-699 | protein | denotes | p107 |
| T22 | 781-785 | protein | denotes | p130 |
| T23 | 816-838 | protein | denotes | hypophosphorylated pRb |
| T24 | 847-867 | DNA | denotes | E2F DNA binding site |
| T25 | 869-873 | protein | denotes | p130 |
| T26 | 884-889 | protein | denotes | E2F-4 |
| T27 | 899-902 | protein | denotes | pRb |
| T28 | 924-929 | protein | denotes | E2F-1 |
| T29 | 959-964 | protein | denotes | E2F-4 |
| T30 | 982-994 | DNA | denotes | E2F DNA site |
| T31 | 1034-1039 | protein | denotes | E2F-4 |
| T32 | 1063-1088 | cell_type | denotes | primary hemopoietic cells |
| T33 | 1151-1160 | protein | denotes | alpha-IFN |
| T34 | 1222-1226 | protein | denotes | p130 |
| T35 | 1231-1236 | protein | denotes | E2F-4 |
| T36 | 1238-1247 | protein | denotes | alpha-IFN |
| T37 | 1288-1293 | protein | denotes | E2F-4 |
| T38 | 1315-1340 | cell_type | denotes | primary hemopoietic cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-121 | Sentence | denotes | p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. |
| S2 | 122-342 | Sentence | denotes | We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by alpha-interferon (alpha-IFN). |
| S3 | 343-424 | Sentence | denotes | alpha-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. |
| S4 | 425-681 | Sentence | denotes | However, the change in p130 phosphorylation in response to alpha-IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G1, whereas pRb is dephosphorylated only in G1. |
| S5 | 682-780 | Sentence | denotes | In contrast, p107 is dephosphorylated and is then depleted from cells as they exit the cell cycle. |
| S6 | 781-930 | Sentence | denotes | p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F-4, whereas pRb binds both E2F-4 and E2F-1. |
| S7 | 931-1095 | Sentence | denotes | The phosphorylated forms of E2F-4 that bind to the E2F DNA site are different from hyperphosphorylated E2F-4, which predominates in primary hemopoietic cells in G0. |
| S8 | 1096-1347 | Sentence | denotes | We conclude that although cell cycle arrest induced by alpha-IFN may be mediated in part by formation of a complex containing p130 and E2F-4, alpha-IFN does not induce hyperphosphorylation of E2F-4, which characterizes primary hemopoietic cells in G0. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 0-4 | NP | denotes | p130 |
| C3 | 6-10 | NP | denotes | p107 |
| C4 | 16-19 | NP | denotes | pRb |
| C1 | 0-19 | NP | denotes | p130, p107, and pRb |
| C6 | 104-120 | NP | denotes | alpha-interferon |
| C5 | 83-120 | NP | denotes | cell cycle arrest by alpha-interferon |
| C7 | 168-215 | NP | denotes | the retinoblastoma family (pRb, p107, and p130) |
| C8 | 313-341 | NP | denotes | alpha-interferon (alpha-IFN) |
| C9 | 343-352 | NP | denotes | alpha-IFN |
| C11 | 381-384 | NP | denotes | pRb |
| C10 | 360-384 | NP | denotes | dephosphorylation of pRb |
| C12 | 389-423 | NP | denotes | loss of p130 phosphorylated Form 3 |
| C13 | 484-493 | NP | denotes | alpha-IFN |
| C15 | 529-532 | NP | denotes | pRb |
| C14 | 508-532 | NP | denotes | dephosphorylation of pRb |
| C16 | 553-572 | NP | denotes | loss of p130 Form 3 |
| C17 | 591-605 | NP | denotes | the cell cycle |
| C18 | 634-636 | NP | denotes | G1 |
| C19 | 646-649 | NP | denotes | pRb |
| C20 | 678-680 | NP | denotes | G1 |
| C21 | 695-699 | NP | denotes | p107 |
| C22 | 746-751 | NP | denotes | cells |
| C23 | 755-759 | NP | denotes | they |
| C24 | 765-779 | NP | denotes | the cell cycle |
| C25 | 781-785 | NP | denotes | p130 |
| C26 | 869-873 | NP | denotes | p130 |
| C27 | 884-889 | NP | denotes | E2F-4 |
| C28 | 899-902 | NP | denotes | pRb |
| C30 | 959-964 | NP | denotes | E2F-4 |
| C29 | 931-964 | NP | denotes | The phosphorylated forms of E2F-4 |
| C31 | 965-969 | NP | denotes | that |
| C32 | 1014-1039 | NP | denotes | hyperphosphorylated E2F-4 |
| C33 | 1041-1046 | NP | denotes | which |
| C34 | 1063-1094 | NP | denotes | primary hemopoietic cells in G0 |
| C36 | 1151-1160 | NP | denotes | alpha-IFN |
| C35 | 1122-1160 | NP | denotes | cell cycle arrest induced by alpha-IFN |
| C37 | 1222-1226 | NP | denotes | p130 |
| C38 | 1231-1236 | NP | denotes | E2F-4 |
| C39 | 1238-1247 | NP | denotes | alpha-IFN |
| C41 | 1288-1293 | NP | denotes | E2F-4 |
| C40 | 1264-1293 | NP | denotes | hyperphosphorylation of E2F-4 |
| C42 | 1295-1300 | NP | denotes | which |
| C43 | 1315-1346 | NP | denotes | primary hemopoietic cells in G0 |
| R1 | C7 | C1 | coref-ident | "the retinoblastoma family (pRb, p107, and p130)","p130, p107, and pRb" |
| R2 | C8 | C6 | coref-ident | alpha-interferon (alpha-IFN),alpha-interferon |
| R3 | C9 | C8 | coref-ident | alpha-IFN,alpha-interferon (alpha-IFN) |
| R4 | C11 | C4 | coref-ident | pRb,pRb |
| R5 | C13 | C9 | coref-ident | alpha-IFN,alpha-IFN |
| R6 | C15 | C11 | coref-ident | pRb,pRb |
| R7 | C14 | C10 | coref-ident | dephosphorylation of pRb,dephosphorylation of pRb |
| R8 | C16 | C12 | coref-ident | loss of p130 Form 3,loss of p130 phosphorylated Form 3 |
| R9 | C19 | C15 | coref-ident | pRb,pRb |
| R10 | C20 | C18 | coref-ident | G1,G1 |
| R11 | C21 | C3 | coref-ident | p107,p107 |
| R12 | C23 | C22 | coref-pron | they,cells |
| R13 | C24 | C17 | coref-ident | the cell cycle,the cell cycle |
| R14 | C25 | C2 | coref-ident | p130,p130 |
| R15 | C26 | C25 | coref-ident | p130,p130 |
| R16 | C28 | C19 | coref-ident | pRb,pRb |
| R17 | C30 | C27 | coref-ident | E2F-4,E2F-4 |
| R18 | C31 | C29 | coref-relat | that,The phosphorylated forms of E2F-4 |
| R19 | C33 | C32 | coref-relat | which,hyperphosphorylated E2F-4 |
| R20 | C36 | C13 | coref-ident | alpha-IFN,alpha-IFN |
| R21 | C35 | C5 | coref-ident | cell cycle arrest induced by alpha-IFN,cell cycle arrest by alpha-interferon |
| R22 | C37 | C26 | coref-ident | p130,p130 |
| R23 | C38 | C30 | coref-ident | E2F-4,E2F-4 |
| R24 | C39 | C36 | coref-ident | alpha-IFN,alpha-IFN |
| R25 | C41 | C38 | coref-ident | E2F-4,E2F-4 |
| R26 | C42 | C40 | coref-relat | which,hyperphosphorylation of E2F-4 |
| R27 | C43 | C34 | coref-ident | primary hemopoietic cells in G0,primary hemopoietic cells in G0 |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein_molecule | denotes | p130 |
| T2 | 6-10 | protein_molecule | denotes | p107 |
| T3 | 16-19 | protein_molecule | denotes | pRb |
| T4 | 52-71 | cell_type | denotes | proliferating cells |
| T5 | 83-100 | other_name | denotes | cell cycle arrest |
| T6 | 104-120 | protein_molecule | denotes | alpha-interferon |
| T7 | 149-164 | other_name | denotes | phosphorylation |
| T8 | 172-193 | protein_family_or_group | denotes | retinoblastoma family |
| T9 | 195-198 | protein_molecule | denotes | pRb |
| T10 | 200-204 | protein_molecule | denotes | p107 |
| T11 | 210-214 | protein_molecule | denotes | p130 |
| T12 | 263-276 | cell_line | denotes | Daudi B-cells |
| T13 | 284-299 | other_name | denotes | cell cycle exit |
| T14 | 313-329 | protein_molecule | denotes | alpha-interferon |
| T15 | 331-340 | protein_molecule | denotes | alpha-IFN |
| T16 | 343-352 | protein_molecule | denotes | alpha-IFN |
| T17 | 381-384 | protein_molecule | denotes | pRb |
| T18 | 397-401 | protein_molecule | denotes | p130 |
| T19 | 448-452 | protein_molecule | denotes | p130 |
| T20 | 484-493 | protein_molecule | denotes | alpha-IFN |
| T21 | 529-532 | protein_molecule | denotes | pRb |
| T22 | 561-565 | protein_molecule | denotes | p130 |
| T23 | 646-649 | protein_molecule | denotes | pRb |
| T24 | 678-680 | other_name | denotes | G1 |
| T25 | 695-699 | protein_molecule | denotes | p107 |
| T26 | 781-785 | protein_molecule | denotes | p130 |
| T27 | 816-834 | protein_molecule | denotes | hypophosphorylated |
| T28 | 835-838 | protein_molecule | denotes | pRb |
| T29 | 847-867 | DNA_domain_or_region | denotes | E2F DNA binding site |
| T30 | 869-873 | protein_molecule | denotes | p130 |
| T31 | 884-889 | protein_molecule | denotes | E2F-4 |
| T32 | 899-902 | protein_molecule | denotes | pRb |
| T33 | 924-929 | protein_molecule | denotes | E2F-1 |
| T34 | 959-964 | protein_molecule | denotes | E2F-4 |
| T35 | 982-994 | DNA_domain_or_region | denotes | E2F DNA site |
| T36 | 1034-1039 | protein_molecule | denotes | E2F-4 |
| T37 | 1063-1088 | cell_type | denotes | primary hemopoietic cells |
| T38 | 1092-1094 | other_name | denotes | G0 |
| T39 | 1122-1139 | other_name | denotes | cell cycle arrest |
| T40 | 1151-1160 | protein_molecule | denotes | alpha-IFN |
| T41 | 1222-1226 | protein_molecule | denotes | p130 |
| T42 | 1231-1236 | protein_molecule | denotes | E2F-4 |
| T43 | 1238-1247 | protein_molecule | denotes | alpha-IFN |
| T44 | 1264-1284 | other_name | denotes | hyperphosphorylation |
| T45 | 1288-1293 | protein_molecule | denotes | E2F-4 |
| T46 | 1315-1340 | cell_type | denotes | primary hemopoietic cells |
| T47 | 1344-1346 | other_name | denotes | G0 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 172-186 | Phenotype | denotes | retinoblastoma | HP:0009919 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 172-186 | Disease | denotes | retinoblastoma | http://purl.obolibrary.org/obo/MONDO_0008380 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 83-93 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T2 | 242-252 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T3 | 284-294 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T4 | 595-605 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T5 | 769-779 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T6 | 1071-1088 | Body_part | denotes | hemopoietic cells | http://purl.obolibrary.org/obo/CL_0000988 |
| T7 | 1122-1132 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T8 | 1323-1340 | Body_part | denotes | hemopoietic cells | http://purl.obolibrary.org/obo/CL_0000988 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 269-276 | Cell | denotes | B-cells | http://purl.obolibrary.org/obo/CL:0000236 |
| T2 | 1071-1088 | Cell | denotes | hemopoietic cells | http://purl.obolibrary.org/obo/CL:0000988 |
| T3 | 1323-1340 | Cell | denotes | hemopoietic cells | http://purl.obolibrary.org/obo/CL:0000988 |